EPCAM and cancer: Recent studies have established that EpCAM is overexpressed on CSCs from several cancer types, including breast, colon, pancreas, and prostate tumors (Bakalova et al., 2004; Gires et al., 2009; Li et al., 2007; O’Brien et al., 2007; Ricci-Vitiani et al., 2007).